failure to respond or late response
on 15 May 2017
Last Applicant/ Owned by
1772-J Avenida de Los Arboles, #190
Thousand Oaks
US
CA
91362
Serial Number
87093891 filed on 06th Jul 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The color(s) green, blue, white is/are claimed as a feature of the mark. The mark consists of a green cross with a white sun rising over the horizon in the center of the cross; the words Cruz Verde in a green font color to the right of the green cross; the word America in white font color inside a blue band which is directly under the words Cruz Verde. The English translation of Cruz Verde in thRead More
Acetaminophen; Antacids; Antibiotic creams; Antibiotic handwash; Antibiotic ointments; Antibiotic preparations; Antibiotic tablets; Antibiotics; Antihistamines; Aspirin; Cough drops; Cough syrups; Cough expectorants; Decongestant capsules; Decongestant nasal sprays; Decongestants; Dietary food supplements; Eye drops; Laxatives; Oral analgesics; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents for epidermis; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Sleeping pills/tablets; Suppositories; Topical analgesic creams; Topical analgesics; Vitamin and mineral supplements; Alcohol for pharmaceutical purposes; Aloe vera preparations for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-cough drops; Antibacterial pharmaceuticals; Balms for pharmaceutical purposes; Bee pollen for use as a dietary food supplement; Dermatological pharmaceutical products; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Digestives for pharmaceutical purposes; Ibuprofen for use as an oral analgesic; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Jalap; Menthol for pharmaceutical purposes; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally
No 87093891
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
01.05.01 -
Sun, rising or setting (partially exposed or partially obstructed)
24.13.02 -
Cross, Greek (equal sized lines)
26.11.21 -
Rectangles that are completely or partially shaded
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of a green cross with a white sun rising over the horizon in the center of the cross; the words Cruz Verde in a green font color to the right of the green cross; the word America in white font color inside a blue band which is directly under the words Cruz Verde.
Status Date | Action Taken |
---|---|
15th May 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
15th May 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
17th Oct 2016 | ASSIGNED TO EXAMINER |
17th Oct 2016 | NON-FINAL ACTION WRITTEN |
17th Oct 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
17th Oct 2016 | NON-FINAL ACTION E-MAILED |
12th Jul 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
11th Jul 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
09th Jul 2016 | NEW APPLICATION ENTERED IN TRAM |